Investing in health for all

Moderator: 1:30 p.mKey note and fire hazard discussion

1. Werner HoyerPresident of the European Investment Bank
2. Tedros Adhanom GhebreyesusDirector General of the World Health Organization

1:55 p.mQuestion and answer with international media

1. Werner HoyerPresident of the European Investment Bank
2. Tedros Adhanom GhebreyesusDirector General of the World Health Organization

2:05 p.mClosing remarks

1. Stella KyriakidesCommissioner for Health and Food Safety of the European Commission

2:10 p.mbreakingSession One – Anatomy of Resistance
Despite earlier warnings that the world is vulnerable to a pandemic, the COVID-19 crisis has been an unprecedented shock to our current health system and has shown that many countries are completely unprepared for such preparations. What will it take to build health systems that are capable and ready to deal with future diseases and health emergencies?2:25 p.mOpening remarks

1. Thomas OstrosVice President of the European Investment Bank

2:30 p.mPanel discussion

1. Marie-Ange directoryManaging Director of Fundraising, Private Sector Partnerships and Innovative Finance at Gavi Vaccine Alliance
2. John F. RyanActing Deputy Director General of the Directorate General of Health and Food Safety of the European Commission
3. Samira AsmaAssistant Director-General for Information, Analysis and Delivery at the World Health Organization
   
4. Felicity RiedlDirector of Innovation and Competitiveness at the European Investment Bank

3:00 PMClosing remarks

1. Sandra DoroDirector General of Health and Food Safety of the European Commission

3:05 p.mbreakingPart Two – Competition Against Disease
Over the past century, mankind has made great strides in combating infectious diseases through improved hygiene and sanitation, as well as the development and deployment of vaccines and treatments. But continuing disparities in access underscore the need for new approaches to funding research and innovation in infectious diseases, new treatments, care models, and innovation.3:20 PMOpening remarks

1. Bad signActing Director General of Research and Innovation at the European Commission

3:25 p.mPanel discussion

1. Jeremy FarraraWelcome Trust Director
2. Irene Norstedt.European Commission Research and Innovation Directorate General Director Public Directorate
3. Wolfgang PhilipDirector General of the European Commission’s Health Emergency Preparedness and Response Authority
4. John ReederDirector of the Special Program for Research and Training in Tropical Diseases of the World Health Organization

3:55 p.mClosing remarks

1. Laura PiovesanDeputy Director General of the Projects Directorate of the European Investment Bank

4:00 PMbreakingPart three – Health without borders
Achieving “good health and well-being for all” requires a shared purpose and a broad collaborative effort by people and organizations across countries and sectors – public and private. Although geopolitical tensions are greater than they have been in decades, greater public-health coordination among governments, international institutions, countries, and international networks is needed.4:15 p.mOpening remarks

1. Martin SichelDeputy Director General of the Directorate General of International Partnerships at the European Commission

4:20 PMPanel discussion

1. Ozlem TuresiCo-Founder and Chief Medical Officer of BioNTech
2. Peter Piot.Special Adviser to the President of the European Commission on Covid-19
3. Gaudenz SilberschmidtDirector of Health and Multilateral Partnerships at the World Health Organization
4. TBD

4:50 PMClosing remarks

1. Christoph KuhnDirector of the Mandate Management Department at the European Investment Bank

4:55 p.mClosing key note

1. TBD